ADHD Stimulant Medications: Comparative Overview and Selection Guide

Stimulant Classes

ClassFormulations (Brand/Generic)DurationKey Features
Methylphenidate (MPH)Ritalin IR, Ritalin LA, Concerta (OROS), Daytrana (patch), Focalin XR (d-MPH), Metadate CD, Quillivant XR (liquid)4–12 hFirst-line; multiple delivery systems; d-MPH (Focalin) = 2× potency
Mixed Amphetamine Salts (MAS)Adderall IR/XR, Mydayis (16 h)4–16 hd- & l-amphetamine; slightly more norepinephrine effect
Lisdexamfetamine (Vyvanse)Prodrug → d-amphetamine10–14 hLower abuse potential (requires hydrolysis); consistent absorption
DextroamphetamineDexedrine IR/Spansule, Zenzedi, ProCentra (liquid)4–10 hPure d-isomer

Non-Stimulant Options (Often Adjunctive)

  • Guanfacine XR (Intuniv): α₂A agonist – improves prefrontal regulation; sedation, hypotension.
  • Clonidine XR (Kapvay): α₂ agonist – more sedating; helpful for aggression, tics, sleep.
  • Atomoxetine (Strattera): NRI – 4–6 weeks onset; no abuse potential.
  • Viloxazine (Qelbree): NRI + serotonin modulation; newer.

Selection Factors

  • Age, comorbidities (anxiety, tics, cardiac, substance use), duration needed, swallowing ability, insurance formulary, side effect profile, patient/family preference.
  • Trial: Start low, titrate weekly; monitor height, weight, BP, HR, sleep, appetite.

~70–80% respond to first stimulant tried; most non-responders respond to the other class.

Prescription Medications - Related Articles